Danske Bank’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1 Hold
1
﹤0.01% 1164
2025
Q4
$1 Hold
1
﹤0.01% 1554
2025
Q3
$1 Hold
1
﹤0.01% 1479
2025
Q2
$1 Hold
1
﹤0.01% 1511
2025
Q1
$1 Hold
1
﹤0.01% 1360
2024
Q4
$1 Hold
1
﹤0.01% 1397
2024
Q3
$1 Buy
+1
New +$1 ﹤0.01% 1586

Other funds holding LUCD

Danske Bank's LUCD Position: Q1 2026 in Review

Danske Bank held its Lucid Diagnostics (LUCD) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1164.

Danske Bank first reported a position in LUCD in Q3 2024 and has held it in 7 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Danske Bank held 1 share of Lucid Diagnostics worth $1 as of Q1 2026.
  • Danske Bank left its Lucid Diagnostics share count unchanged in Q1 2026.
  • Lucid Diagnostics made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #1164 holding.
  • Danske Bank first reported a position in Lucid Diagnostics in Q3 2024 and has held it in 7 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.